On Nov. 29, 2020, Moderna announced a supply agreement with the UK government for an additional 2 million doses of mRNA-1273, Modernaﾒs vaccine candidate against COVID-19, to the UK beginning in March 2021. To-date, the UK government had secured 7 million doses of mRNA-1273.